4.7 Review

Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment

期刊

FRONTIERS IN PHARMACOLOGY
卷 12, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2021.732403

关键词

corona virus disease 2019; corona virus disease 2019 treatment; severe acute respiratory syndrome corona virus 2 variants; antimicrobials; immunotherapy; traditional Chinese medicine

向作者/读者索取更多资源

The COVID-19 outbreak since December 2019 has posed a huge threat to global public health. Various clinical studies are evaluating the efficacy of different treatments against COVID-19 to control and prevent the spread of the outbreak.
Since the outbreak of corona virus disease 2019 (COVID-19) in Wuhan (China) in December 2019, the epidemic has rapidly spread to many countries around the world, posing a huge threat to global public health. In response to the pandemic, a number of clinical studies have been initiated to evaluate the effect of various treatments against COVID-19, combining medical strategies and clinical trial data from around the globe. Herein, we summarize the clinical evaluation about the drugs mentioned in this review for COVID-19 treatment. This review discusses the recent data regarding the efficacy of various treatments in COVID-19 patients, to control and prevent the outbreak.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据